Financial Year |
March 31 2023 |
Monetary Funds |
1,741,358,303.28 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
39,086,385.66 |
Accounts Receivable |
452,300,117.37 |
Advances to Suppliers |
193,647,040.37 |
Other Receivables |
30,433,778.76 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
7,560,000.00 |
Dividend Receivable |
-- |
Inventories |
144,128,988.16 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
14,179,511.62 |
Total Current Assets |
3,783,086,626.49 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
188,511,303.96 |
Long-term Equity Investment |
201,175,311.05 |
Investment Properties |
25,045,301.14 |
Fixed Assetes |
519,700,836.22 |
Under-construction Projects |
10,899,974.31 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
124,055,671.87 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
547,918.01 |
Deferred Income Tax Assets |
38,779,821.84 |
Other Non-Current Assets |
7,901,114.70 |
Sub-Total of Non-Current Assets |
1,116,617,253.10 |
Total Assets |
4,899,703,879.59 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
47,389,041.20 |
Accounts Payable |
1,045,025,933.92 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
37,058,005.24 |
Taxes Payable |
5,482,067.66 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
9,431,349.53 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
36,342,048.60 |
Sub-Total of Current Liabilities |
1,673,507,488.98 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
37,786.58 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
57,058,582.26 |
Total Liabilities |
1,730,566,071.24 |
Paid-In Capital(Or Share Stock) |
535,990,000.00 |
Capital Surplus |
935,708,779.20 |
Surplus Reserve |
218,480,792.29 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,467,904,978.63 |
Minority Stockholder's Interest |
-- |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,169,137,808.35 |
Owner's Equity(Stockholder's Equity) |
3,169,137,808.35 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
4,899,703,879.59 |